Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

AARP “Rx Watchdog Report” Will Analyze Price Increases Ahead Of Medicare Discount Cards

This article was originally published in The Pink Sheet Daily

Executive Summary

The new publication series kicks off with a study on brand name drug price increases by manufacturers from 2000-2003. showing WAC for widely used brand drugs rose an average of 23.6% versus cumulative inflation of 10.4%. “Watchdog” reports on generic drug and first quarter 2004 price hikes are in the pipeline.

You may also be interested in...



Brand Rx Prices Increased Half A Percent On Average From July To September

AARP/University of Minnesota pricing survey finds the average rate of increase for 197 drugs slowed in comparison to the 1% rise in prices between April and June and the 3.5% increase observed from January to March.

Brand Rx Prices Increased Half A Percent On Average From July To September

AARP/University of Minnesota pricing survey finds the average rate of increase for 197 drugs slowed in comparison to the 1% rise in prices between April and June and the 3.5% increase observed from January to March.

Generic Drug Average Annual Price Increase Is Four Times Inflation – AARP

The AARP “Watchdog” report on generic drug prices calculates the average annual increase in list prices as 8.7% from 2001 to 2003. The annual rate of general inflation for the same period was 2.2%. About half of the 75 drugs sampled either had no price change or decreased in price.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS059506

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel